06-Mar-2014 - A GSK-led consortium will develop manufacturing technologies in a Government-backed scheme intended to safeguard the UK drug production sector.
News in brief
06-Mar-2014 - Boehringer Ingelheim says it will pump a further €330m ($453m) into a German manufacturing facility critised by the US FDA in its rejection of the drug empagliflozin.
06-Mar-2014 - The US FDA has released draft guidance on how post-approval manufacturing changes should be reported in annual reports.
04-Mar-2014 - Eli Lilly says investment in its Sao Paolo, Brazil packaging plant will support growth for the local market.
04-Mar-2014 - The EMA stressed the potential benefits of continuous process validation in guidance issued this week and underlined that data submitted by drugmakers must demonstrate the adequacy of production operations at each site.
03-Mar-2014 - Bayer has predicted double digit growth in its Chinese consumer health business as it acquires OTC firm Dihon Pharmaceutical Group.
27-Feb-2014 - Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.
27-Feb-2014 - National prioritization, investments in healthcare infrastructure and building better epidemiological and cost databases could bring more innovative medicines to middle-income countries, according to an independent study conducted by Charles River Associates.
Processing: Featured news
Simon Sturge leaves Boehringer Ingelheim to head Merck's biosimilars unit, as well as the European Medicines Agency, Shire and EFPIA in this week's People on the Move column.
AstraZeneca was one of the first pharmaceutical companies in the world to adopt Toyota's 'lean manufacturing' methods. in-Pharmatechnologist.com visited the firm's plant in Södertälje to find out what impact this way of working is having on productivity.